[
  {
    "ts": null,
    "headline": "GEHC Expands BARDA Collaboration With $35M Boost for AI Ultrasound",
    "summary": "GE HealthCare expands its BARDA deal by $35M to speed AI-enabled ultrasound and next-gen imaging for trauma care and mass casualty readiness.",
    "url": "https://finnhub.io/api/news?id=12fa5421dfd923559c52828bdbbdc6959c3fa34bab8d5e1de0b1e760cc88dc07",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771438140,
      "headline": "GEHC Expands BARDA Collaboration With $35M Boost for AI Ultrasound",
      "id": 139139356,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ISRG",
      "source": "Yahoo",
      "summary": "GE HealthCare expands its BARDA deal by $35M to speed AI-enabled ultrasound and next-gen imaging for trauma care and mass casualty readiness.",
      "url": "https://finnhub.io/api/news?id=12fa5421dfd923559c52828bdbbdc6959c3fa34bab8d5e1de0b1e760cc88dc07"
    }
  },
  {
    "ts": null,
    "headline": "SSKN Stock Falls Despite Meta-Analysis Backs Excimer Laser's Efficacy",
    "summary": "STRATA Skin Sciences plunges 8% despite new meta-analysis backing its 308 nm excimer laser with up to 85% PASI improvement in plaque psoriasis.",
    "url": "https://finnhub.io/api/news?id=997619aab624e6a22eee90d5e46dd7a4a1d55c46b9e1e10984f3cf4b1f7862cb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771426260,
      "headline": "SSKN Stock Falls Despite Meta-Analysis Backs Excimer Laser's Efficacy",
      "id": 139136674,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ISRG",
      "source": "Yahoo",
      "summary": "STRATA Skin Sciences plunges 8% despite new meta-analysis backing its 308 nm excimer laser with up to 85% PASI improvement in plaque psoriasis.",
      "url": "https://finnhub.io/api/news?id=997619aab624e6a22eee90d5e46dd7a4a1d55c46b9e1e10984f3cf4b1f7862cb"
    }
  },
  {
    "ts": null,
    "headline": "Reasons to Hold HealthEquity Stock in Your Portfolio for Now",
    "summary": "HQY rides on strong HSA growth, AI-driven efficiency gains and solid Q3 results, though data security threats remain a key risk.",
    "url": "https://finnhub.io/api/news?id=20d6f9b732001259a7ccf0d5e1b3989e74bd234ed4ffc9a317f4ef19a9fbbf03",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771426080,
      "headline": "Reasons to Hold HealthEquity Stock in Your Portfolio for Now",
      "id": 139136973,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ISRG",
      "source": "Yahoo",
      "summary": "HQY rides on strong HSA growth, AI-driven efficiency gains and solid Q3 results, though data security threats remain a key risk.",
      "url": "https://finnhub.io/api/news?id=20d6f9b732001259a7ccf0d5e1b3989e74bd234ed4ffc9a317f4ef19a9fbbf03"
    }
  },
  {
    "ts": null,
    "headline": "BOTZ: Will Robotics And 'Embodied AI' Take The Baton?",
    "summary": "Global X Robotics & AI ETF (BOTZ) balances industrial and information tech sectors. Read here to know why we rate BOTZ ETF a HOLD.",
    "url": "https://finnhub.io/api/news?id=2a699d1ea4905d4eccb50795a556ab8206de7114609ae70437063fb18c8dc6a5",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771401600,
      "headline": "BOTZ: Will Robotics And 'Embodied AI' Take The Baton?",
      "id": 139133251,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2242726119/image_2242726119.jpg?io=getty-c-w1536",
      "related": "ISRG",
      "source": "SeekingAlpha",
      "summary": "Global X Robotics & AI ETF (BOTZ) balances industrial and information tech sectors. Read here to know why we rate BOTZ ETF a HOLD.",
      "url": "https://finnhub.io/api/news?id=2a699d1ea4905d4eccb50795a556ab8206de7114609ae70437063fb18c8dc6a5"
    }
  },
  {
    "ts": null,
    "headline": "Does Strong da Vinci Growth and 2026 Guidance Change The Bull Case For Intuitive Surgical (ISRG)?",
    "summary": "In recent days, Intuitive Surgical reported a strong past quarter, with revenue rising 19% year over year on higher procedure volumes and more da Vinci system placements, alongside improved non‑GAAP profitability. The company also highlighted robust adoption of its da Vinci 5 and SP platforms and guided for 13–15% global da Vinci procedure growth in 2026, underlining how procedure expansion is reinforcing its recurring instruments and services business. Next, we’ll examine how this strong...",
    "url": "https://finnhub.io/api/news?id=de74e4b119af34829a56bfd4800a68aa21b19b1be71a6861b36034722229d1ff",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771391490,
      "headline": "Does Strong da Vinci Growth and 2026 Guidance Change The Bull Case For Intuitive Surgical (ISRG)?",
      "id": 139129968,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ISRG",
      "source": "Yahoo",
      "summary": "In recent days, Intuitive Surgical reported a strong past quarter, with revenue rising 19% year over year on higher procedure volumes and more da Vinci system placements, alongside improved non‑GAAP profitability. The company also highlighted robust adoption of its da Vinci 5 and SP platforms and guided for 13–15% global da Vinci procedure growth in 2026, underlining how procedure expansion is reinforcing its recurring instruments and services business. Next, we’ll examine how this strong...",
      "url": "https://finnhub.io/api/news?id=de74e4b119af34829a56bfd4800a68aa21b19b1be71a6861b36034722229d1ff"
    }
  },
  {
    "ts": null,
    "headline": "Intuitive Surgical Revenue Growth And AI Push Shape Robotic Surgery Outlook",
    "summary": "Intuitive Surgical (NasdaqGS:ISRG) reported 19% year-over-year revenue growth in fiscal 2025 Q4. Growth was driven by higher procedure volumes and increased placements of da Vinci robotic systems. The company is expanding the use of artificial intelligence across its platforms. Recent AI efforts include work on robotic bronchoscopies and lung biopsies. Intuitive Surgical, the maker of the da Vinci robotic surgery systems, sits at the center of the shift toward minimally invasive...",
    "url": "https://finnhub.io/api/news?id=31e210e46d690faf53581fdf6d2a136b0a9b7749da7658b31287c4bef4fe3b21",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771389427,
      "headline": "Intuitive Surgical Revenue Growth And AI Push Shape Robotic Surgery Outlook",
      "id": 139129969,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ISRG",
      "source": "Yahoo",
      "summary": "Intuitive Surgical (NasdaqGS:ISRG) reported 19% year-over-year revenue growth in fiscal 2025 Q4. Growth was driven by higher procedure volumes and increased placements of da Vinci robotic systems. The company is expanding the use of artificial intelligence across its platforms. Recent AI efforts include work on robotic bronchoscopies and lung biopsies. Intuitive Surgical, the maker of the da Vinci robotic surgery systems, sits at the center of the shift toward minimally invasive...",
      "url": "https://finnhub.io/api/news?id=31e210e46d690faf53581fdf6d2a136b0a9b7749da7658b31287c4bef4fe3b21"
    }
  }
]